The safety and tolerability of this treatment will be assessed using subjects' self-report of symptoms, the validated Hyperthyroid Symptom Scale (HSS), and blood pressure measurements. The impact of this treatment on remyelination will be done by comparing visual evoked potentials (VEPs) before and after treatment.